For research use only. Not for therapeutic Use.
A 205804 (Cat.No:I010575) is a selective inhibitor of the protein kinase p38 MAP kinase alpha isoform. It has shown to have potential therapeutic effects in various inflammatory diseases, including rheumatoid arthritis, psoriasis, and chronic obstructive pulmonary disease. A 205804 has been used as a tool compound for the study of p38 MAP kinase signaling pathways in preclinical research.
Catalog Number | I010575 |
CAS Number | 251992-66-2 |
Synonyms | 4-[(4-Methylphenyl)thio]thieno[2,3-c]pyridine-2-carboxamide |
Molecular Formula | C15H12N2OS2 |
Purity | ≥95% |
Target | Integrin |
Solubility | Soluble to 100 mM in DMSO and to 10 mM in ethanol |
Storage | Store at 4℃ |
IUPAC Name | 4-(4-methylphenyl)sulfanylthieno[2,3-c]pyridine-2-carboxamide |
InChI | InChI=1S/C15H12N2OS2/c1-9-2-4-10(5-3-9)19-13-7-17-8-14-11(13)6-12(20-14)15(16)18/h2-8H,1H3,(H2,16,18) |
InChIKey | QQGWEXFLMJGCAL-UHFFFAOYSA-N |
SMILES | CC1=CC=C(C=C1)SC2=C3C=C(SC3=CN=C2)C(=O)N |